Related Articles
PREPARATION OF MOUSE-HUMAN CHIMERIC ANTIBODY AGAINST PANCREATIC CANCER-ASSOCIATED MUCIN
Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.
Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils
A novel Tn antigen epitope‑recognizing antibody for MUC1 predicts clinical outcome in patients with primary lung adenocarcinoma
A novel monoclonal antibody, H9, directed against the core protein of MUC1 mucin.